Take-Home Dosing Experiences among Persons Receiving Methadone Maintenance Treatment During COVID-19

Mary C. Figgatt, Zach Salazar, Elizabeth Day, Louise Vincent, Nabarun Dasgupta
doi: https://doi.org/10.1101/2020.08.31.20185249

Article Information

doi 
https://doi.org/10.1101/2020.08.31.20185249
History 
  • September 2, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Mary C. Figgatt1,2,*,
  2. Zach Salazar3,
  3. Elizabeth Day3,
  4. Louise Vincent3 and
  5. Nabarun Dasgupta1
  1. 1Injury Prevention Research Center, University of North Carolina at Chapel Hill
  2. 2Department of Epidemiology, University of North Carolina Gillings School of Global Public
  3. 3North Carolina Survivors Union
  1. ↵*Corresponding author: Mary Figgatt, Permanent address: 725 Martin Luther King Blvd, CB# 7505, Chapel Hill, NC 27599; email: mfiggatt{at}unc.edu
Back to top
Posted September 02, 2020.
Download PDF
Data/Code
Email
Take-Home Dosing Experiences among Persons Receiving Methadone Maintenance Treatment During COVID-19
Mary C. Figgatt, Zach Salazar, Elizabeth Day, Louise Vincent, Nabarun Dasgupta
medRxiv 2020.08.31.20185249; doi: https://doi.org/10.1101/2020.08.31.20185249
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area